qtr-three adjusted ffo per share $num-one.
compname reports qtr-four revenue up num-one% to num-two% to $num-two billion.
qtrly hotel adjusted ebitda was a $num-one million loss, a marked improvement from a loss of $3.8 million in qtr-two of year-five.
qtr-two adjusted ebitda $num-one million versus refinitiv ibes estimate of $1.7 billion.
qtr-three adjusted ffo per share $num-one excluding items.
compname reports third quarter year-six results and announces $num-one million share repurchase program.
qtrly net operating loss at corporate noi level was $num-one million per month.
qtrly hotel occupancy increased from num-two% in july to num-three% in august.
qtr-two revenue $num-one million versus refinitiv ibes estimate of $1.04 billion.
qtr-three adjusted ffo per share $num-three.
qtr-four revenue rose num-one percent to $num-one million.
qtr-one revenue $num-one million versus refinitiv ibes estimate of $1.06 billion.
compname reports qtr-three revenue of $num-three million versus refinitiv ibes estimate of $1.02 billion.
sees at least one of the num-one vaccines in phase iii trials could announce positive findings in next num-two days with broad distribution by mid-year-six.
compname reports qtr-three adjusted earnings per share $num-two.
compname reports qtr-two year-six results and announces num-one hotels open and operating.
